Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas

BACKGROUND: Whereas 40 % to 70 % of papillary thyroid carcinomas (PTCs) are characterized by a BRAF mutation (BRAF(mut)), unified biomarkers for the genetically heterogeneous group of BRAF wild type (BRAF(wt)) PTCs are not established yet. Using state-of-the-art technology we compared RNA expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulten, Hans-Juergen, Alotibi, Reem, Al-Ahmadi, Alaa, Ata, Manar, Karim, Sajjad, Huwait, Etimad, Gari, Mamdooh, Al-Ghamdi, Khalid, Al-Mashat, Faisal, Al-Hamour, Osman Abdel, Al-Qahtani, Mohammad Hussain, Al-Maghrabi, Jaudah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315163/
https://www.ncbi.nlm.nih.gov/pubmed/25922907
http://dx.doi.org/10.1186/1471-2164-16-S1-S6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315163/
https://www.ncbi.nlm.nih.gov/pubmed/25922907
http://dx.doi.org/10.1186/1471-2164-16-S1-S6

Ejemplares similares